Hello, you are using an old browser that's unsafe and no longer supported. Please consider updating your browser to a newer version, or downloading a modern browser.
Realizing the full potential of Real World Evidence (RWE) across the drug development lifecycle requires robust and representative sources of Real World Data. We have partnered with the leading data contributors across the healthcare data landscape to assemble a powerful array of secondary data assets, including pharmacy and medical claims, laboratory and EMR data. Together, these data assets form an unparalleled range and depth of RWD at our disposal for addressing the evidence needs of our clients.
Our epidemiologists and data scientists possess intimate familiarity with the structures, strengths and limitations of each data asset, and we put this knowledge to work in selecting the right data sources to address your research objectives.